Urinary Incontinence - 2018 Pipeline Insight Report - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Urinary Incontinence - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

This report offers a comprehensive insight of the pipeline (under development) therapeutics scenario and growth prospects across Urinary Incontinence development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Scope

• The report provides a snapshot of the pipeline development for Urinary Incontinence
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for Urinary Incontinence
• The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Urinary Incontinence
• The report also covers the dormant and discontinued pipeline projects related to Urinary Incontinence

Companies Featured

• Astellas Pharma Inc.
• Celogos
• Cook MyoSite Incorporated
• FemmePharma Global Healthcare Inc.
• GTx Inc.
• Innovacell Biotechnologie AG
• Ipsen S.A.
• Outpost Medicine Limited
• Taiho Pharmaceutical Co. Ltd.
• Takeda Pharmaceutical Company Limited
• TheraVida Inc.

Key Topics Covered

1. Report Introduction

2. Urinary Incontinence Overview

3. Pipeline Therapeutics

• An Overview of Pipeline Products for Urinary Incontinence

4. Comparative Analysis

5. Products in Clinical Stage

5.1 Drug Name: Company Name

• Product Description
• Research and Development
• Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

6.1 Drug Name: Company Name

• Product Description
• Research and Development
• Product Development Activities

7. Therapeutic Assessment

• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type

8. Inactive Products

8.1 Drug Name: Company Name

• Product Description
• Research and Development
• Product Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/3t8jxw/urinary?w=4